MX9102702A - ALPHA ADMINISTRATION INTERFERED THROUGH ORAL INHALATION TO TREAT ASTHMA AND PROLIFERATIVE, NON-MALIGNANT LUNG DISEASES. - Google Patents

ALPHA ADMINISTRATION INTERFERED THROUGH ORAL INHALATION TO TREAT ASTHMA AND PROLIFERATIVE, NON-MALIGNANT LUNG DISEASES.

Info

Publication number
MX9102702A
MX9102702A MX9102702A MX9102702A MX9102702A MX 9102702 A MX9102702 A MX 9102702A MX 9102702 A MX9102702 A MX 9102702A MX 9102702 A MX9102702 A MX 9102702A MX 9102702 A MX9102702 A MX 9102702A
Authority
MX
Mexico
Prior art keywords
interfered
proliferative
lung diseases
oral inhalation
treat asthma
Prior art date
Application number
MX9102702A
Other languages
Spanish (es)
Inventor
Robert J Spiegel
Francis M Cuss
Keith B Nolop
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX9102702A publication Critical patent/MX9102702A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
MX9102702A 1990-12-21 1991-12-19 ALPHA ADMINISTRATION INTERFERED THROUGH ORAL INHALATION TO TREAT ASTHMA AND PROLIFERATIVE, NON-MALIGNANT LUNG DISEASES. MX9102702A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63156590A 1990-12-21 1990-12-21
US63155290A 1990-12-21 1990-12-21

Publications (1)

Publication Number Publication Date
MX9102702A true MX9102702A (en) 1992-06-01

Family

ID=27091422

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102702A MX9102702A (en) 1990-12-21 1991-12-19 ALPHA ADMINISTRATION INTERFERED THROUGH ORAL INHALATION TO TREAT ASTHMA AND PROLIFERATIVE, NON-MALIGNANT LUNG DISEASES.

Country Status (6)

Country Link
AU (1) AU9132091A (en)
IE (1) IE914444A1 (en)
IL (1) IL100415A0 (en)
MX (1) MX9102702A (en)
PT (1) PT99837A (en)
WO (1) WO1992011025A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU738838B2 (en) 1996-09-12 2001-09-27 Valentis, Inc. Compositions and methods for pulmonary gene delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
DK264787A (en) * 1986-05-27 1987-11-28 Schering Corp APPLICATION OF HUMANT ALFA INTERFERON FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION
CA1297788C (en) * 1986-10-22 1992-03-24 Judith Feinberg Treatment of aids virus with recombinant human alpha interferon
EP0294160A1 (en) * 1987-06-02 1988-12-07 Schering Corporation Treatment of chronic type b hepatitis with a combination of recombinant human alpha and gamma interferons
ZA895010B (en) * 1988-07-05 1990-03-28 Schering Corp Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferion
US4959210A (en) * 1988-11-01 1990-09-25 Schering Corporation Treatment of genital warts with a combination of liquid nitrogen and recombinant DNA human alpha interferon
ATE92333T1 (en) * 1988-12-01 1993-08-15 Schering Corp MEDICATIONS FOR THE INTRALESION TREATMENT OF SCALP-LIKE CELL CARCINOMA WITH RECOMBINANT HUMAN ALPHA INTERFERON.

Also Published As

Publication number Publication date
IL100415A0 (en) 1992-09-06
IE914444A1 (en) 1992-07-01
AU9132091A (en) 1992-07-22
PT99837A (en) 1992-12-31
WO1992011025A2 (en) 1992-07-09
WO1992011025A3 (en) 1992-09-17

Similar Documents

Publication Publication Date Title
DK479189D0 (en) INHALER
NO921110D0 (en) inhaler
DE3888838D1 (en) RESPIRATORY MASK.
DE59000161D1 (en) RESPIRATORY MASK.
IT8619625A0 (en) PHARMACEUTICAL COMPOSITIONS FOR INHALATION.
HUP0101293A3 (en) Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use
IL78913A (en) Synthetic vaccines for foot and mouth disease,their preparation and use
DE3369682D1 (en) 2-substituted 1-aminoalkyl-1,2,3,4-tetrahydro-beta-carbolines, their preparation and use as medicaments
NO893062L (en) USE OF ISOKINOLIC COMPOUNDS, SPECIFICALLY INHALATION PREPARATIONS.
ATE271852T1 (en) IMPROVED INHALATION PREPARATIONS
IL65184A (en) Preparation comprising glycyrrhizin for the treatment of dermal,including oral diseases
MX9102702A (en) ALPHA ADMINISTRATION INTERFERED THROUGH ORAL INHALATION TO TREAT ASTHMA AND PROLIFERATIVE, NON-MALIGNANT LUNG DISEASES.
MX9102512A (en) ORAL ADMINISTRATION OF ALPHA INTERFERON IN THE TREATMENT OF LUNG DISEASES.
ZA816417B (en) Pharmaceutical composition,especially for treating infectious diseases of the respiratory tract
DE59203456D1 (en) Liposomes containing volatile inhalation anesthetics, their preparation and use.
DE3865818D1 (en) MEDICINAL PREPARATION FOR INHALATION APPLICATIONS.
JPS57176949A (en) Novel carnitine derivative, manufacture and remedy for burn, epythelial disease and respiratory disease
JPS57176950A (en) Novel carnitine derivative, manufacture and remedy for burn, epythelial disease and respiratory disease
FI963753A0 (en) A new drug to treat respiratory viral disease
ZA919959B (en) Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
KR890004440U (en) Powder inhalation prevention mask
ITFI920029U1 (en) INHALER TO ADD AIR TO INSPIRE, FOR USE IN THE PRESENCE OF HARMFUL ATMOSPHERES.
NO932380D0 (en) inhaler
SE9603354D0 (en) Powder inhales IV
NO882983D0 (en) ORAL DOSAGE FOR INTERFERON FOR HUMAN USE.